Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Reexamination Certificate
2011-01-04
2011-01-04
Kim, Taeyoon (Department: 1651)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
C424S093100, C435S325000
Reexamination Certificate
active
07862810
ABSTRACT:
Methods, compositions, and kits for repairing damaged myocardium and/or myocardial cells including the administration cytokines are disclosed and claimed. Methods and compositions for the development of large arteries and vessels are also disclosed and claimed. The present application also discloses and claims methods and media for the growth, expansion, and activation of human cardiac stem cells.
REFERENCES:
patent: 5197985 (1993-03-01), Caplan et al.
patent: 5199942 (1993-04-01), Gillis
patent: 5202120 (1993-04-01), Silver et al.
patent: 5434134 (1995-07-01), Gluckman et al.
patent: 5543318 (1996-08-01), Smith et al.
patent: 5580779 (1996-12-01), Smith et al.
patent: 5602301 (1997-02-01), Field
patent: 5833975 (1998-11-01), Paoletti et al.
patent: 5906934 (1999-05-01), Grande et al.
patent: 5908782 (1999-06-01), Marshak et al.
patent: 5942235 (1999-08-01), Paoletti
patent: 5990091 (1999-11-01), Tartaglia et al.
patent: 6001934 (1999-12-01), Yamanaka et al.
patent: 6004777 (1999-12-01), Tartaglia et al.
patent: 6036972 (2000-03-01), Nakamura et al.
patent: 6099832 (2000-08-01), Mickle et al.
patent: 6110459 (2000-08-01), Mickle et al.
patent: 6117675 (2000-09-01), Van der Kooy et al.
patent: 6130066 (2000-10-01), Tartaglia et al.
patent: 6174333 (2001-01-01), Kadiyala et al.
patent: 6255292 (2001-07-01), Liang
patent: 6265189 (2001-07-01), Paoletti et al.
patent: 6329348 (2001-12-01), Crystal et al.
patent: 6387369 (2002-05-01), Pittenger et al.
patent: 6547787 (2003-04-01), Altman et al.
patent: 2002/0061587 (2002-05-01), Anversa
patent: 2002/0122792 (2002-09-01), Stegmann
patent: 2003/0054973 (2003-03-01), Anversa
patent: 2003/0105015 (2003-06-01), Gilbertson et al.
patent: 2004/0258669 (2004-12-01), Dzau et al.
patent: 2005/0158859 (2005-07-01), Artavanis-Tsakonas et al.
patent: 11-246433 (1999-09-01), None
patent: WO 92/11865 (1992-07-01), None
patent: WO 95/12979 (1995-05-01), None
patent: WO 95/14079 (1995-05-01), None
patent: WO 95/28174 (1995-10-01), None
patent: WO 95/34581 (1995-12-01), None
patent: WO 96/04314 (1996-02-01), None
patent: WO 96/38544 (1996-12-01), None
patent: WO 99/45775 (1999-09-01), None
patent: WO 9949015 (1999-09-01), None
patent: WO 00/06710 (2000-02-01), None
patent: WO 00/57922 (2000-10-01), None
patent: WO 01/26694 (2001-04-01), None
patent: WO 01/34179 (2001-05-01), None
patent: WO 01/94420 (2001-12-01), None
patent: WO 2005/038014 (2005-04-01), None
Young et al. 1995. Mesenchymal Stem Cells Reside Within the Connective Tissues of Many Organs. Developmental Dynamics 202:137-144.
Nakamura et al. 2000. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J. Clin. Invest. 106:1511-1519.
Yamamura et al. 2001. IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart. Am J Physiol Heart Circ Physiol. 280: H1191—H1200.
Segers et al. 2008. Stem-cell therapy for cardiac disease. Nature 451:937-942.
Huang, Jul-Han et al. “Protein Transfer of Preformed MHC-Peptide Complexes Sensitizes Target Cells to T Cell Cytolysis,”Immunity, vol. 1: 607-613, Oct. 1994.
Ross, Russell, “The pathogenesis of atherosclerosis: a perspective for the 1990s,” Nature, vol. 362: 801-809, Apr. 1993.
Sensebe, Luc, et al., The Broad Spectrum of Cytolune Gene Expression by Myoid Cells from the Human Marrow Microenvironment,Stem Cells, vol. 15: 133-143, Nov. 2, 1997.
Wartiovaara, Ulla, et al., “Peripheral Blood Platelets Express VEGF-C and VEGF which are Released during Platelet Activation,”Thromb Haemost, vol. 80: 171-175, 1998.
Mohle, Robert, et al., “Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets,”Proc. Natl. Acad. Sci. USA, vol. 94: 663-668, Jan. 21, 1997.
Boyden, Stephen, “The Chemotactic Effect of Mixtures of Antibody and Antigen on Polymorphonuclear Leucocytes,”J Exptl. Med.vol. 115: 453-456, 1962.
American Heart Association. 2001 Heart and Stroke Statistical Update. Dallas, Texas: American Heart Association, 2000.
Bautz, F. et al., “Expression and secretion of vascular endothelial growth factor-A by cytokine stimulated hematopoietic progenitor cells. Possible role in the hernatopoietic microenvironment.”Exp Hematol, vol. 28(6):700-706, Jun. 2000.
Beardsle, M. A. et al., “Rapid turnover of connexin43 in the adult rat heart.”Circ. Res.vol. 83: 629-635, 1998.
Beltrarmi, C.A. et al., “Structural basis of end-stage failure in ischemic cardiomyopathy in humans.”Circulationvol. 89: 151-163, 1994.
Bianco, P. et al. “Bone marrow stromal stem cells: nature, biology, and potential applications.”Stem Cellsvol. 19:180-192, 2001.
Blume et al., “A review of autologous hematopoietic cell transplantation.”Biology of Blood&Marrow Transplantation, vol. 6: 1-12, 2000.
Bodine, D.M. et al., “Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor.”Blood, vol. 84: 1482-1491, 1994.
Breier, G. et al., “Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system.”Blood, vol. 87: 630-641, 1996.
Brugger et al., “Ex vivo manipulation of hematopoietic stem and progenitor cells.”Seminars in Hematology, vol. 37 (1): 42-49, 2000.
Caceres-Cortes, J.R. et al., “Steel factor sustains SCL expression and the survival of purified CD34+ bone marrow cells in the absence of detectable cell differentiation.”Stem Cellsvol. 19(1):59-70, Jan. 2001.
Chiu et al., “Cellular Cardiomyoplasty: Mycardial Regeneration With Satellite Cell Implantation.”Ann. Thorac. Surg., vol. 60: 12-18, 1995.
Clutterbuck, R.D. et al., “G-CSF mobilization of haemopoietic cell populations in SCID mice engrafted with human leukaernia.”Bone Marrow Transplant, vol. 20(4):325-332, Aug. 1997.
Couper, L.L. et al., “Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1.”Circ. Res., vol. 81: 932-939, 1997.
Durocher, D. et al., “The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors.”EMBO J., vol. 16: 5687-5696, 1997.
Fielding et al., “Autologous bone marrow transplantation.”Curr. Opin. Hematology, vol. 1: 412-417, 1994.
Gussoni et al., “Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation.”Nature, vol. 356:435-438, 1992.
Hermann, H. and Aebi, U. “In Subcellular Biochemistry: Intermediate Filaments.” vol. 31 (ed. Henmann, H. & Harris, E.): 319-362 (Plenum Press, New York, 1998).
Huang H.M. et al., “Optimal proliferation of a hematopoietic progenitor cell line requires either costitnulation with stem cell factor or increase of receptor expression that can be replaced by over expression of Bcl-2.”Blood, vol. 93(8):2569-2577, Apr. 1999.
Ikuta, K. et al., “Mouse hematopoietic stem cells and the interaction of c-kit receptor and steel factor.”International Journal of Cell Cloning, vol. 9:451-460, 1991.
Janowska-Wieczorek, A. et al., “Autocrine/paracrine mechanisms in human hematopoiesis.”Stem Cells, vol. 19:99-107, 2001.
Jo, D.Y. et al., “Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-I .”The Journal of Clinical Investigation, vol. 105(1): 101-111, Jan. 2000.
Kachinsky, A.M. et al., “Intermediate filaments in cardiac myogenesis: nestin in the developing mouse heart.”J. Histochem. Cytochem., vol. 43: 843-847, 1995.
Kanj et al., “Myocardial ischemia associated with high-dose carmustine infusion.”,Cancer, vol. 68 (9):1910-1912, 1991.
Kajstura, J. et al., “The cellular basis
Cooley LLP
Kim Taeyoon
New York Medical College
LandOfFree
Methods and compositions for the repair and/or regeneration... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for the repair and/or regeneration..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for the repair and/or regeneration... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2722444